Kiora Pharma (KPHMW) Stock Price, News & Analysis
Company Description
Kiora Pharma (OTC Link: KPHMW) is a publicly traded company.
On a trailing twelve-month basis, Kiora Pharma reported revenue of $0 with net income of -$11K and diluted earnings per share of $-2.64.
This page provides a comprehensive overview of KPHMW stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
KPHMW Rankings
Latest News
SEC Filings
Kiora Pharma has filed 5 recent SEC filings, including 4 Form 4, 1 Form 8-K. The most recent filing was submitted on July 2, 2026. SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all KPHMW SEC filings →
Financial Highlights
operating income reached -$12.8M, and net income was -$11K. Diluted earnings per share stood at $-2.64. The company generated -$10.0M in operating cash flow. With a current ratio of 5.99, the balance sheet reflects a strong liquidity position.